2015
DOI: 10.1016/j.phytochem.2015.05.014
|View full text |Cite
|
Sign up to set email alerts
|

Further C-15-acyl phragmalin derivatives from Chukrasia tabularis A. Juss.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 12 publications
0
10
0
Order By: Relevance
“…Compound (479) significantly promotes neurite outgrowth from PC12 cells in a dose-dependent manner in the presence of NGF (20 ng/mL) at concentrations ranging from 0.1 to 50.0 μM, possessing strong NGF-potentiating activities on PC12 cells while compounds (247, 480, 481) were inactive 168 . At 10 μM, compounds (251,263,310,476) significantly enhanced the TNFα-induced NF-κβ luciferase activity approximately by two folds to more or less equal in comparison to TNFα-treated positive control group 175 452,401,496,482,488,521,495,530,528,497,493,453,497,431,299,318,413,475,481 and 418 mol ratio/32 pmol TPA respectively 188,243,244,472 . Compound (295) showed the highest potency to increase the nerve growth factor (NGF) production in C6 astrocytes (glioma cells) with the level of secreted NGF of 152.41 % (cell viability is (109.44 %) while in compound (493), the level of secreted NGF was 103.61 % (cell viability is (105.09 %) 192 .…”
Section: Antineoplastic Activitymentioning
confidence: 94%
See 1 more Smart Citation
“…Compound (479) significantly promotes neurite outgrowth from PC12 cells in a dose-dependent manner in the presence of NGF (20 ng/mL) at concentrations ranging from 0.1 to 50.0 μM, possessing strong NGF-potentiating activities on PC12 cells while compounds (247, 480, 481) were inactive 168 . At 10 μM, compounds (251,263,310,476) significantly enhanced the TNFα-induced NF-κβ luciferase activity approximately by two folds to more or less equal in comparison to TNFα-treated positive control group 175 452,401,496,482,488,521,495,530,528,497,493,453,497,431,299,318,413,475,481 and 418 mol ratio/32 pmol TPA respectively 188,243,244,472 . Compound (295) showed the highest potency to increase the nerve growth factor (NGF) production in C6 astrocytes (glioma cells) with the level of secreted NGF of 152.41 % (cell viability is (109.44 %) while in compound (493), the level of secreted NGF was 103.61 % (cell viability is (105.09 %) 192 .…”
Section: Antineoplastic Activitymentioning
confidence: 94%
“…Toonaciliatone G (399) possesses additional keto carbonyl at C12 when compared to Toonayunnanin I. Toonaciliatone E ( 400) is acetylated form of previously reported toonaciliatin B 223 . The double bond at ∆ 14,15 in previously isolated Turraflorin G 224 is replaced by an oxirane ring in Turrapubin D (401). Toonayunnanin G (402) differs from Toonayunnanin I in reduction of ∆ 1,2 double bond and Toonacilianin I ( 403) is a C12 hydroxyl form of compound (402).…”
Section: Vilasininmentioning
confidence: 98%
“…Toonaciliatone G (399) possesses additional keto carbonyl at C12 when compared to Toonayunnanin I. Toonaciliatone E ( 400) is acetylated form of previously reported toonaciliatin B 223 . The double bond at ∆ 14,15 in previously isolated Turraflorin G 224 is replaced by an oxirane ring in Turrapubin D (401). Toonayunnanin G (402) differs from Toonayunnanin I in reduction of ∆ 1,2 double bond and Toonacilianin I ( 403) is a C12 hydroxyl form of compound (402).…”
Section: Vilasininmentioning
confidence: 99%
“…. Compounds (265, inhibitory effect against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells with IC 50 value of 452,401, 496,482, 488, 521, 495, 530, 528, 497, 493, 453, 497,431,299,318,413,475,481 and 418 mol ratio/32 pmol TPA respectively…”
mentioning
confidence: 99%
“…Further phragmalin derivatives, chukvelutilides I 517-X 532, have been isolated from Chukrasia tabularis. 161 This paper adds to the confusion in the literature by using duplicate names (chukvelutilides I-O). In addition, chukvelutilides U and V are the same as the previously published chukvelutilides I and L.…”
Section: Tetranortriterpenoidsmentioning
confidence: 99%